Navigation Links
Ampio Pharmaceuticals Reports Full-Year 2011 Financial Results and Milestone Highlights for 2011
Date:2/9/2012

GREENWOOD VILLAGE, Colo., Feb. 9, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), today announced financial results for the year ended December 31, 2011, and offered a summary of the milestones during 2011.

Financial ResultsTotal revenues recognized for the year ended December 31, 2011, were $18,750, reflecting the amortized portion of the $500,000 licensing upfront payment from the Company's agreement with a major Korean pharmaceutical company for South Korean rights to Ampio's Zertane™.  The Company did not report any revenues for the year ended December 31, 2010.  

Total operating expenses for the full-year periods ended December 31, 2011 and 2010, were $11,152,891 and $6,704,405, respectively.  Research and development expenses for the full year 2011 were $6,648,397, compared to $1,972,134 for the full year 2010.  The 237% growth in research and development costs during 2011 primarily reflects the increased focus on the Company's multiple clinical trials and proof-of-concept studies.  Specifically, the Company invested significantly in the Phase 2 Ampion™ in the Knee study and the Phase 2 Optina™ study evaluating the product's ability to prevent diabetic macular edema (DME) and in a $2,000,000 fee paid to obtain a product technology license associated with Zertane™.  

General and administrative expenses for the full-year period of 2011 were $4,504,494, compared to $4,732,271 in the full-year period of 2010.  Other expenses were $7,142,593 in the full-year period of 2011, compared to $1,348,990 in the corresponding 2010 period.  The increase in other expenses primarily reflects the $5,585,422 of non-cash changes in the fair value of Ampi
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
2. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
3. Atlanta-based Med Tech Company CardioMEMS Raises Additional Capital to Advance its CHAMPION Clinical Trial for its Wireless Sensor System for Heart Failure Monitoring
4. U.S. Patent Issued for Champions Biotechnologys Lead Oncology Drug
5. Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer
6. Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
7. Chay Enterprises Inc. Completes Merger With Repurposed Drug Developer Ampio Pharmaceuticals, Inc.
8. Ampio Pharmaceuticals, Inc. Retains Redwood Consultants, LLC to Assist in Shareholder Relations and Strategic Planning
9. Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc.
10. Ampio Pharmaceuticals, Inc. Appoints New Chairman and Chief Financial Officer
11. Higher Education Leaders Receive TCWF Champions of Health Professions Diversity Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 Royal Philips (NYSE: PHG, ... Performance Leader in Imaging Equipment in the 2013 Best ... also received Best in KLAS and Best in Category ... 128 Computed Tomography (CT), Ingenia 1.5T and 3.0T ... The annual Best in KLAS Awards: Medical Imaging & ...
(Date:6/18/2013)... June 18, 2013  Specialty Coating Systems ... in Parylene coating technologies: SCS microRESIST™ Antimicrobial ... of Parylene with antimicrobial properties to effectively ... components. (Logo: http://photos.prnewswire.com/prnh/20130618/DE33772LOGO ... increase and continue to pose a challenge ...
(Date:6/18/2013)... -- Decision Resources, one of the world,s leading research and ... the past 12 months, 25 percent of surveyed physicians from ... , Italy , Spain ... have been required to change the antiretroviral (ARV) prescription for ... costs. Additionally, more than 40 percent of respondents report that ...
Breaking Medicine Technology:Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS 2Specialty Coating Systems Announces New Antimicrobial Parylene Technology 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3
... Nov. 7, 2011 Zimmer Holdings, Inc. ... agreed to sell $550 million of senior notes in an ... Smith Incorporated, BNP Paribas Securities Corp. and RBS Securities ... LLC, Credit Suisse Securities (USA) LLC, Citigroup Global Markets ...
... 7, 2011 ERT (Nasdaq: ERT ), ... President and CEO is scheduled to present at the ... on Nov. 15, 2011 in Las Vegas. ... Company,s corporate website at http://www.ert.com . The webcast ...
Cached Medicine Technology:Zimmer Holdings, Inc. Agrees to Sell $550 Million of Senior Notes 2ERT to Present at the Citi 2011 Global Health Care Conference on November 15, 2011 2
(Date:6/18/2013)... Medical Center clinical researchers have launched an innovative ... evaluate the ability of a patient,s own stem ... peripheral arterial disease (PAD). , Led by ... University Hospitals Case Medical Center,s Harrington Heart & ... Western Reserve University School of Medicine, the clinical ...
(Date:6/18/2013)... Belleville, Ill. (PRWEB) June 18, 2013 More ... older are living with HIV/AIDS, according to the Centers for ... don’t know they are infected. In support of National HIV ... Social Security Disability Insurance (SSDI) representation, the CDC ... HIV testing. , The CDC reports about 50,000 new ...
(Date:6/18/2013)... 2013 myCNAjobs announces the addition of ... articles, and tips to the Caregiver Resources Center. , ... the 10,000+ retiring baby boomers each day, the need ... job resources has never been greater. myCNAjobs, ... community, recently launched the first-ever free resource center for ...
(Date:6/18/2013)... 18, 2013 A new $119 million ... burgeoning aquaculture industry is redefining the way consumers get ... most acclaimed personal culinary chefs on the Emerald Coast ... of sustainable seafood and the promising industry of aquaculture. ... days. Many consumers strive to fully partake in the ...
(Date:6/18/2013)... Pomona, Calif. (PRWEB) June 18, 2013 ... associate professor of Family Medicine for the College of ... of Health Sciences has been elected president of the ... Gov. Edmund G. Brown Jr. appointed Connett, a 1984 ... , OMBC members recently elected Connett to the position ...
Breaking Medicine News(10 mins):Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Allsup Observes National HIV Testing Day June 27 2Health News:Allsup Observes National HIV Testing Day June 27 3Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2Health News:New $119 Million Industry Swimming Up the East Coast 2
... likely to be infected with Hepatitis C virus compared ... get treatment for their liver disease because current antiviral ... this epidemiological background, the article by Schaefer and colleagues, ... important study in the field, write Sanjeev Arora and ...
... 72 posters, lectures, and mini-symposia given by University of Pennsylvania ... new research findings on the molecular workings of several types ... American Society of Cell Biology takes place on December 1-5, ... Huntington,s Disease: A new role has been discovered for ...
... 3 inVentiv Health, Inc.,(Nasdaq: VTIV ) today ... be held Tuesday, December 11th, 2007 in New York ... 9:00 a.m. as announced earlier, and,will conclude at noon, ... business overview, presentations by the,leaders of each of the ...
... N.C., Dec. 3 LipoScience, Inc. is pleased to,announce ... of Directors., Mr. Landon has over 30 years ... retiring from active management, Mr. Landon,was Vice President & ... full functional responsibility for all of DuPont,s Medical,Products businesses, ...
... research from a lab at Florida State University reveals ... it, resisting temptations to misbehave, our fuel tank is ... , Florida State psychologist Roy F. Baumeister and his ... M. Tice, Florida State, showed this with an experiment ...
... An inhaled immune system stimulant protects mice against ... and fungal infections of the lungs, a research ... Texas M. D. Anderson Cancer Center reports at ... have implications for protecting immuno-compromised patients against infection ...
Cached Medicine News:Health News:Treating patients with psychiatric disorders for hepatitis C 2Health News:Penn talks at ASCB touch on cancer, neurodegenerative diseases, and MD 2Health News:inVentiv Health Provides Updated Information on December 11th Investor Day 2Health News:inVentiv Health Provides Updated Information on December 11th Investor Day 3Health News:Got sugar? Glucose affects our ability to resist temptation 2Health News:Aerosol launches immune response in lungs to wipe out lethal infections 2Health News:Aerosol launches immune response in lungs to wipe out lethal infections 3
... ,Offers an average 5:1 increase in usage time ... of a standard cannula. , ,The combination ... ambulatory oxygen patients a superior alternative to liquid ... warranty. , ,NOTE: ...
Redesigning the World's Oxygen Therapy One Device at a Time. , ,Everything you like about our OXYMATIC 400 Series conservers, only better!...
... Accutrol is similar in design to the ... incorporates a temperature probe at the tip ... can accurately determine the patient's core body ... accuracy comparable to a pulmonary artery catheter ...
... Ultra Micro Shafts For Insertion Through A ... Light-Weight ... Shafts For A More Comfortable Approach., ,Recessed ... Cap Supplied For Protection Of Jaws During ...
Medicine Products: